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Abstract
Introduction: Sub-Saharan Africa is a subcontinent with a proud cultural richness and diversity, yet inexplicably also
a region with severe health care challenges and inequity. To challenge this health equity gap and reduce the
burden of disease, the patient’s voice in monitoring and evaluation of health and health care interventions is
paramount. The aim of this two-phased review is to map the availability of patient-reported outcome measures
(PROMs) in a selection of non-English, African Languages, and systematically evaluate the measurement properties
of the PROMs that were identified.
Methods: This systematic review will be conducted in two phases. In phase 1, we will scope the literature for patient-
reported outcome measures (PROMs), either developed from scratch or through translation and validation in a sub-Saharan
African country and a selection of non-English, African languages (n = 31; spoken in > 10 million people and/or a national
language). The availability of PROMs will be mapped against the previously reported burden of disease in the respective
countries included. Subsequently, in phase 2, we systematically evaluate the measurement properties of these PROMs using
the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology for systematic
reviews on PROMs. To ensure rigour, secondary searches will be developed to specifically locate articles that report on the
measurement properties of the PROMs identified during phase 1. The evidence will be graded using the modified GRADE
approach.
Discussion: This review will provide a comprehensive overview and quality appraisal of PROMs developed in non-English,
African languages. Consequently, this review when concluded may be an important first step in promoting access to these
PROMs for use in clinical practice and research, as well as facilitate identification and prioritization of key knowledge gaps.
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Background
The World Health Organization (WHO) defines univer-
sal health coverage as “all people having access to the
health services they need, when and where they need
them, without financial hardship”. It includes the full
range of essential health services, from health promotion
to prevention, treatment, rehabilitation, and palliative
care [1]. Furthermore, it is highlighted that good health
care systems are rooted in communities and focus not
only on preventing and treating disease and illness but
also on helping to improve well-being and quality of life
[1]. The latter, well-being and quality of life, are two
prime examples of patient-reported outcomes; outcomes
commonly assessed using patient-reported outcome
measures (PROMs). Some examples of common PROMs
for health-related quality of life include the EuroQol
EQ-5D or the Short Form 36 Health Survey [2, 3]. Such
PROMs are increasingly used to assess an aspect of a pa-
tient’s health status that can be directly derived from the
patient without interpretation of the patient’s response
by anyone other than the patient [4]. Well-being and
quality of life are merely two examples, and other
patient-reported outcomes are those related to mental
health (e.g. depression, anxiety), health literacy (e.g. dis-
ease knowledge or attitude), measures of activity (e.g.
physical activity), or societal participation amongst
others. Albeit used increasingly, in particular with the
context of clinical trials, there have been repeated calls
for the inclusion of the “patient’s voice” in the real-
world context during prospective data collection [5–7].
Sub-Saharan Africa is a world region characterised by a
proud and rich diversity in cultures and languages. How-
ever, sub-Saharan Africa is also a world region with rap-
idly increasing levels of multidimensional poverty [8], and
a shifting burden of disease (e.g. communicable towards
non-communicable disease) [9], financial constraints, geo-
graphical challenges, and lack of human resources [10].
Amongst others, these pertinent factors perpetuate a com-
plex system of health inequality. One can argue that the
richness and diversity in languages and cultures (in sub-
Saharan Africa), in combination with complex low-
resource settings, complicates adequate and comprehen-
sive evaluation in a clinical and/or academic context. In-
novative and bottom-up approaches are required in
tackling these complex challenges (e.g. health inequality)
[11], while safeguarding the tremendous richness and di-
versity. High-quality PROMs, suitable to the local context
(e.g. language, cultural validity), may assist such bottom-
up innovation by promoting inclusivity throughout aca-
demia and health care.
The average number of living languages per country
in sub-Saharan Africa is estimated to be 57, while in
some countries (e.g. Nigeria) as many as > 500 recog-
nised languages are spoken [12]. In about half (46%)
of the forty-eight sub-Saharan African countries, Eng-
lish is one of the commonly spoken languages [12].
Yet, despite English being a common language, only a
mere ~ 16% of the total sub-Saharan African popula-
tion speaks some level of English (> 169 million
people); either as a first language or second language
(see online supplement 1) [12]. Other common lan-
guages spoken include Swahili (> 108 million), Arabic
(> 88 million), French (> 75 million), and Hausa (> 71
million). With most PROMs developed in languages
commonly spoken in “developed” countries, one can
argue that there may be a significant gap in the avail-
ability of (and access to) PROMs that are linguistic-
ally and contextually valid. In light of the shifting
burden of disease [9, 13–15], such gaps may be more
pronounced for some outcomes or some disease clus-
ters [16]. The overarching aim of this review is there-
fore to improve access to contextually validated and
language-appropriate PROMs of high quality, to im-
prove their use in academia and clinical practice, and
consequently to facilitate the inclusivity of more pa-
tients’ voices.
The objectives of this review are therefore threefold (i)
to scope the literature of studies conducted in sub-
Saharan Africa on the use and measurement properties
of PROMs in commonly spoken sub-Saharan African
languages; (ii) indirectly, map the availability of non-
English PROMs against the most recent reported burden
of disease and International Classification of Functioning
(ICF); and (iii) systematically evaluate the measurement
properties of the PROMs identified under the first
objective.
Methods/design
This systematic review will comprise two phases, based
on a single yet broad selection of studies (see Fig. 1).
The first phase entails scoping the literature to identify
studies that report on (i) the development (e.g. transla-
tion), (ii) use and/or (iii) evaluation (e.g. validity, reliabil-
ity) of PROMs in non-English languages commonly
spoken (see Table 1) and conducted in one of 48 sub-
Saharan African countries. Once a rigorous overview of
PROMs has been established based on the broad and
scoping search, in phase 2, we will systematically review
the measurement properties for each of the PROMs
identified by systematically collating the results from ar-
ticles relevant to that specific PROM. The systematic
evaluation of measurement properties will be conducted
as guided by the procedures outlined by the Consensus-
based standards for the Selection of Health Measure-
ment Instruments (COSMIN) group [2, 11, 13, 14] and
will be registered as a systematic review in an applicable
repository at the time (e.g. PROSPERO).
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Fig. 1 PRISMA-based flowchart. Articles that report on the use, development, or measurement properties of a PROM will be included. Corresponding
authors will be contacted to consult on additional PROMs that may not have arisen from the search, and forward citation hashing will be used to
identify articles that cited the work included and are deemed eligible for inclusion. Once this iterative process does not lead to new PROMs being
identified phase 1 has been completed (availability). Moving to phase 2, secondary searches will be performed for each identified PROM to ensure all
articles about measurement properties for each of the identified PROMs are allocated and considered. The quality of all individual studies reporting on
measurement properties is evaluated using standard criteria. End products include a minimum of two systematic reviews (availability of PROMs, and
on the quality of PROMs) as well as the start of a PROM repository
Heine et al. Trials          (2021) 22:380 Page 3 of 8
Identify relevant studies
A comprehensive and broad initial search strategy has
been developed for the identification of relevant studies
and PROMs in PubMed, Web of Science, CINAHL, and
AfricaWide. An example of the search strategy
(PubMed) can be found in online supplement 2. In
short, the search combines the following:
(i) All countries in sub-Saharan Africa according to
the World Bank (medical subject headings, and
Title/Abstract),
(ii) the 31 languages (see Table 1) spoken by > 10
million people supplemented with national
languages spoken by < 10 million people [12], and
(iii)a search block for the identification of PROMs
(developed by Oxford University; available at www.
cosmin.nl).
Due to the initial scoping nature of our inquiry, the
framework provided by Arksey and O’Malley will be
followed while cognisant of the refinements suggested
by the Joanna Briggs Institute and others [17–19].
Amendments to the search strategy may be made as
the research team gets more familiar with the body of
evidence. Three methods have been built in, in
addition to the comprehensive search, to support
rigour. First, grey literature will be sought using the
forward citation hashing in Google Scholar of articles
included in phase 1. The addition of grey literature is
deemed particularly important in the African context,
where access to publishing in (open-access) inter-
national journals is often challenging [20]. Second,
corresponding authors of included articles will be
consulted to advise on any additional PROMs they
are aware of, in any of the languages indicated, be-
yond those identified during the initial study selection
process. This process is repeated until no further
PROMs are being identified. If no new PROMs are
identified, secondary searches will be conducted for
each of the identified PROMs (including name varia-
tions, abbreviations, etc.) in conjunction with the
country search block and a search block to identify
any articles that evaluate measurement properties spe-
cifically that may have been missed during the broad
search [21].
Study selection
Studies will be screened against the following prelimin-
ary inclusion and exclusion criteria, however, in line
with the scoping nature of this initial phase, these can be
revised once the research team gains more familiarity
with the body of evidence [18]. Initial inclusion criteria
require that the study is conducted in one of the sub-
Saharan African countries, as identified by the World
Bank (see online supplement 1) and reports on one or
more measurement properties, the use of a PROM in
clinical research, the development of a PROM, or the
evaluation of the interpretability of the PROMs of inter-
est in line with the COSMIN framework [4, 22].
In the instance that studies explicitly report on the use
of a PROM without reporting on one or more of the
measurement properties, a concerted effort will be made
to track back to the original work in developing that
PROM. No language or time restrictions will be applied
during the search, and a concerted effort will be made to
obtain assistance in case articles surface in a non-
English language that is outside the language skillset of
the research team (i.e. Afrikaans, French). A first initial
screening of study titles will be conducted by a single re-
viewer (MH). Subsequently, titles and abstracts are
assessed for potentially relevant articles and the selection
of abstracts for full-text review will be conducted by two
independent reviewers (MH and CvZ). If a study seems
relevant by at least one reviewer based on the abstract,
or in case of doubt, the article will be pushed to full-text
review. Inclusion and exclusion of full-text articles are
done by two reviewers independently, and a third re-
viewer will be consulted in case of irreconcilable dis-
agreements between the first two reviewers. The study
selection process will be streamlined using the open-
access platform CADIMA (www.cadima.info).
In this review, a PROM is defined as “any report of the
status of a patient's health condition that comes directly
from the patient, without interpretation of the patient's
response by a clinician or other, and assessed using self-
administered questionnaires” [23]. Structured question-
naires, though completed by an observer (so-called
ObSROMs), are also eligible for inclusion. ObSROMs
are those in which “observations can be made, appraised,
and recorded by a person other than the patient (e.g.
caregiver) and do not require specialized professional
training” [24]. While these ObSROMs provide an ap-
praisal from the viewpoint of an observer (rather than
directly from the patient), we deem the inclusion of
these ObSROMs particularly valuable in relation to
some of the adverse social determinants of health (e.g.
low literacy).
Phase 1: scoping review on all available PROMs
The included articles will be evaluated in two distinct
phases. In phase 1, a charting form will be developed
using an iterative process (to allow for refinement early
in the data extraction process), and include the follow-
ing: first author, title, year, article type (e.g. journal art-
icle, thesis), journal or article source, country, PROM
characteristics (name, version, outcome measured by the
PROM, licensing model/accessibility), making use of the
ICF where possible [25], language(s), original language
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of development (e.g. English), recall period, target popu-
lation, number of subscales and items, mode of adminis-
tration, time for completion), study populations (e.g.
healthy, specific condition, or age group), and purpose
of use of the PROM (i.e. use in a trial, development of
PROM or evaluation of measurement properties
assessed (e.g. content validity)). This phase provides us
with an overview of all available PROMs in any of the
included languages. The availability of PROMs will sub-
sequently be mapped against the burden of disease in
the respective countries included by using (i) the Insti-
tute for Health Metrics and Evaluation recurring global
burden of disease study [13], (ii) the proportion of the
population in each country that is proficient in the
Table 1 Overview of languages included relative to the total population. Level indicates the national (1), provincial (2), or used for
wider communication (3). See online supplement 1 for the comprehensive overview. Languages spoken by > 10 million people plus
national languages (level 1) are included
Summary statistics
Total population 1,072,128,000
N English speaking 169,531,510
Mean (SD) living languages 57 (85)
Mean (SD) literacy rate 65% (20%)
Languages spoken by > 10 million Language N spoken Level Ranking (max 94)
Swahili 108,888,800 1 1
French 88,135,710 1 2
Arabic 75,160,000 1 3
Hausa 71,219,000 2 4
Pidgin 62078,000 3 5
Amharic 56,900,000 1 6
Yoruba 42,209,000 2 7
Portuguese 29,311,250 1 8
Igbo 29,000,000 2 9
Zulu 27,300,000 1 10
Sotho 27,230,000 1 11
Xhosa 19,150,000 1 12
Oromo 19,100,000 2 13
Afrikaans 17,287,000 1 14
Fulfulde 16,169,000 3 15
Somali 14,635,600 1 16
Setswana 13,630,000 1 17
Wolof 12,522,000 3 18
Jula 12,504,000 3 19
Kinyarwanda 11,600,000 1 20
Rundi 10,420,000 1 21
Ibibio 10,380,000 3 22
+ National languages Malagasy 7,520,000 1 28
Tsonga 5,680,000 1 36
Sango 5,100,000 1 38
Swati 4,800,000 1 40
Ndebele 4,100,000 1 42
Venda 2,910,000 1 48
Creole 2,151,200 1 52
Spanish 787,000 1 67
Kabuverdianu 492,000 1 76
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languages included [12], and (iii) the ICF model [25].
Mapping the availability of PROMs relative to the bur-
den of disease, across the proportion of the population
that is proficient in specific languages, and aligned with
the ICF model will be a first step in identifying potential
knowledge gaps. Albeit, additional strategies will be
needed to inform evidence-based recommendations (see
Dissemination and future perspectives).
Data extraction is conducted by one reviewer and veri-
fied by a second reviewer. The data extraction process
will be piloted on a random sample of six articles with
percentage agreement needing to be > 80% across re-
viewers to begin formal extraction [4, 26, 27]. Any dis-
agreements will be discussed, the data-extraction
template revised if applicable, and a new random selec-
tion of six articles is made until agreement is > 80%.
Phase 2: a systematic review of the quality of PROMs
In phase 2, an overview of all evidence of the quality of
all available PROMs will be obtained. All studies in
which a (version of a) PROM was developed (e.g. trans-
lated or developed from scratch), or in which one or
more of the measurement properties were evaluated will
be included in this review. The COSMIN methodology
for systematic reviews of PROMs will be used to conduct
the review [4], and the review will be registered in a rele-
vant repository. In summary, after extracting the data
from each article (e.g. results about the measurement
properties, interpretability, and feasibility aspects) the
study quality will be assessed using the COSMIN check-
list [26, 28], and the results per study are compared
against the criteria of good measurement properties (see
Table 1 in Prinsen et al. 2018) [4]. Per PROM, and
measurement property, all evidence will be summarized,
and the quality of the evidence graded, using a modified
GRADE approach [4]. Measurement properties will be
defined in line with the published taxonomy [22], and
assessed where applicable, in the following order:
 PROM development, content validity (including face
validity) [28]
 Structural validity, internal consistency, cross-
cultural validity, measurement invariance
 Reliability, measurement error, criterion validity,
hypotheses testing for construct validity, and
responsiveness.
Theoretically, no judgement can be made on the qual-
ity of a PROM when information on the content validity
of that PROM is lacking [28]. However, as it is not un-
likely that a PROM has been developed in language A,
and only additional measurement properties (e.g. cross-
cultural validity) in language B, all measurement proper-
ties are considered; even in the absence of reports on
content validity for a specific PROM in a sub-Saharan
African language.
The quality assessment of each study, quality assess-
ment of each PROM (i.e. applying the criteria for good
measurement properties against each result), and the
grading of the evidence is conducted by two independ-
ent reviewers. This phase provides us with an overview
of all evidence for the quality (i.e. regarding the nine
measurement properties) that is available for each
PROM, available in any of the included languages, and
will be reported according to set reporting guidelines
[29]. It is not our immediate aim to develop recommen-
dations about the most suitable PROM to use, as we will
include PROMs for any outcome, and various patient
populations; the aim is to collect the evidence derived
from phases 1 and 2 into a PROM-repository to pro-
mote access.
Dissemination and future perspectives
This review will be published in peer-reviewed journals,
and when possible, as a multipart series. We foresee that
the scope of evidence derived from this review will allow
for stratified reporting on the availability (phase 1) of
PROMs, as well as the quality of PROMs (phase 2). Fur-
thermore, when the scope of evidence allows it, we can
consider stratified reporting based on specific domains
of the ICF (e.g. activity, participation), disease profiles,
or quality aspects (e.g. content validity). As referred to,
the global burden of disease study, in conjunction with
the ICF model, will be used as a framework to map the
availability of PROMs (see phase 1) [13]. In addition to
journal articles, results of this review will be (i) pre-
sented at global and continental scientific conferences,
and (ii) a technical and executive summary will be
drafted and shared with professional bodies and other
stakeholders within the African continent that focus on
clinical research.
The team foresees important future perspectives that
further aim to disseminate and strengthen the review find-
ings. Firstly, it is the ambition that the PROMs which are
identified through this review will be aggregated in an on-
line, open-access repository. The review of measurement
properties will provide invaluable evidence to add to this
repository that can assist stakeholders in the decision
making, use, and appraisal of PROMs specific for their
context. Similar platforms exist, for example for clinical
assessment outcomes (i.e. PROQOLID™; eprovide.mapi-
trust.org) or meetinstrumentenzorg.nl; yet these are not
tailored to the unique African setting. The underlying be-
lief is that this repository may facilitate wider access to the
PROMs reviewed, and their evidence-base, for use in clin-
ical practice or academic ventures. Direct access or refer-
ence to the instrument may be included, depending on
the PROM’s licensing model; where needed we can work
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with or incentivize stakeholders to unlock the use of spe-
cific PROMS more easily and promote access. Once a re-
pository has been established many other parameters of
interest may be added, including detailed information on
PROM analyses (e.g. scoring methods, cut-off values,
handling of missing data, additional languages, other
modes of administration, amongst others). The research
team aims to closely work with a diverse set of stake-
holders to help guide both content and ways of dissemin-
ation of the repository to cater for all potential users.
Second, consensus-based (e.g. through Delphi methods)
recommendations can be developed for prioritizing the
translation, development, and/or validation of additional
or new PROMs. These recommendations could, for in-
stance, be informed by the local burden of disease (e.g.
disease-specific gaps), specific populations being excluded
from research (e.g. language- or culture-specific gaps), or
perceived relevance for specific outcomes in driving health
policy (e.g. outcome-specific gaps). Mapping the availabil-
ity of PROMs against existing frameworks (i.e. burden of
disease, ICF model) may provide a starting point for such
a consensus procedure. Participatory action research
methods can be used to engage patients and stakeholders
in the prioritization process, to ensure that outcomes rele-
vant to and valued by the patient are equally considered to
those relevant for health policy. Finally, it is the ambition
of the research team, through collaboration with stake-
holders, that key PROMs will be recorded using voice-
overs to ensure that visually impaired or illiterate individ-
uals are not left behind.
Limitations
It is apparent that with an average of 57 living languages
per country, some of which may not be “just spoken”
(e.g. hand signals) or some “just spoken” (e.g. not writ-
ten), it is impossible to include all languages in this re-
view. Besides, as indicated, there is a substantial
proportion of the sub-Saharan African population that is
illiterate. Hence, while this review is comprehensive,
many languages and voices are still excluded. However,
to retain its feasibility, we have opted to include those
languages that are widely spoken (> 10 million people),
supplemented by national languages where applicable.
Once an online repository is established, one could add
additional languages on a per case basis and potentially
use more contemporary methods to include non-written
languages. Furthermore, we acknowledge that while hav-
ing culturally valid and language-appropriate PROMs
may assist research specifically, this is merely one aspect
within a wider set of transformative aspects that may
need to be addressed to further promote inclusivity, in-
cluding power dynamics, scientific trust, and cultural
competencies [30]. A second limitation, given that > 169
million people in sub-Saharan Africa speak English, is
that a similar type of review for PROMs validated in a
sub-Saharan African setting in English may be valuable
as well, in particular concerning the cross-cultural valid-
ity of English PROMs. Though, for reasons of pragma-
tism (i.e. scope of evidence) and feasibility, we chose to
focus the present review specifically on those PROMs
not in English. Thirdly, as the review and search strategy
are focussed on the review of academic literature, there
is a chance that PROMs that have been developed and
studied in local languages may not find their way to the
generally English peer-reviewed literature and will there-
fore be missed in the literature search. To partly address
this limitation, three strategies will be implemented.
First, a content-specific database (AfricaWide) is in-
cluded in the search strategy. Second, the inclusion of
grey literature through forward citation hashing, and
thirdly, corresponding authors of articles included in the
review will be contacted and asked to advise (and pro-
vide documentation where possible) on any unidentified
PROMs in the languages stipulated.
Conclusion
This protocol describes a comprehensive review for the
identification of patient-reported outcome measures,
and their measurement properties, that are developed,
translated, and/or validated in non-English national or
widely spoken languages in sub-Saharan Africa. The out-
come of this review will provide an invaluable resource
for clinicians and academics in the field and aims to pro-
mote inclusivity in health care and research.
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